$18.80
0.412.23%
Pre-Market: 7:03 PM EDT
Comments
Loading...
Rigel Pharmaceuticals Stock Guidance | NASDAQ:RIGL | Benzinga
Rigel Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | RIGL | Rigel Pharmaceuticals | FY | 2025 | — | — | — | $200.00M | $210.00M | $204.88M | Get Alert |
| 01/13/2025 | RIGL | Rigel Pharmaceuticals | FY | 2025 | — | — | — | $200.00M | $210.00M | $193.51M | Get Alert |
| 01/13/2025 | RIGL | Rigel Pharmaceuticals | Q4 | 2024 | — | — | — | $57.60M | $57.60M | $47.42M | Get Alert |
| 01/13/2025 | RIGL | Rigel Pharmaceuticals | FY | 2024 | — | — | — | $179.30M | $179.30M | $169.10M | Get Alert |
| 01/08/2024 | RIGL | Rigel Pharmaceuticals | Q4 | 2023 | — | — | — | $35.70M | $35.70M | $29.78M | Get Alert |
| 01/09/2023 | RIGL | Rigel Pharmaceuticals | Q4 | 2022 | — | — | — | $51.30M | $51.30M | $21.65M | Get Alert |
| 01/10/2022 | RIGL | Rigel Pharmaceuticals | Q4 | 2021 | — | — | — | $20.40M | $20.40M | $23.39M | Get Alert |
| 01/11/2021 | RIGL | Rigel Pharmaceuticals | Q4 | 2020 | — | — | — | $18.40M | $18.40M | $17.81M | Get Alert |
FAQ
What is the most recent guidance for Rigel Pharmaceuticals (RIGL)?
There have been no specific sales or earnings guidance reported for Rigel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.